BEAM

Beam Therapeutics Inc
30.42
-0.60 (-1.93%)
Company Name Stock Ticker Symbol Market Type
Beam Therapeutics Inc BEAM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.60 -1.93% 30.42 10:36:47
Open Price Low Price High Price Close Price Prev Close
31.50 30.1501 31.55 31.02
more quote information »

Recent News

Date Time Source Heading
3/30/202310:00IHNWFeaturedNextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce
3/29/20232:01IHNWFeatured1606 Corp Announces Pivotal Distribution Deal With a Premier CBD Distributor
3/27/202318:24EDGARInitial Statement of Beneficial Ownership (3)
3/27/202318:23EDGARInitial Statement of Beneficial Ownership (3)
3/27/202307:30GLOBEBeam Therapeutics to Participate in the Guggenheim 2023..
3/21/202306:30GLOBEBeam Therapeutics Appoints Gopi Shanker, Ph.D., as Chief..
3/17/202306:05EDGARStatement of Ownership (sc 13g)
3/15/202306:30GLOBEBeam Therapeutics to Participate in the Barclays 2023 Global..
3/01/202306:30GLOBEBeam Therapeutics to Participate in the 43rd Annual Cowen..
2/28/202307:56EDGARSecurities Registration: Employee Benefit Plan (s-8)
2/28/202307:02EDGARCurrent Report Filing (8-k)
2/28/202306:30GLOBEBeam Therapeutics Reports Fourth Quarter and Year-End 2022..
2/14/202308:28EDGARAmended Statement of Ownership (sc 13g/a)
2/10/202311:49EDGARAmended Statement of Ownership (sc 13g/a)
2/10/202306:12EDGARAmended Statement of Ownership (sc 13g/a)
2/09/202308:16EDGARAmended Statement of Ownership (sc 13g/a)
2/07/202306:30GLOBEBeam Therapeutics to Participate in the SVB Securities..
2/02/202316:08EDGARAmended Statement of Ownership (sc 13g/a)
1/30/202316:06EDGARStatement of Changes in Beneficial Ownership (4)
1/20/202316:19EDGARStatement of Changes in Beneficial Ownership (4)
1/09/202307:11EDGARCurrent Report Filing (8-k)
1/09/202306:30GLOBEBeam Therapeutics Reports Progress Across Base Editing..
1/05/202316:07EDGARStatement of Changes in Beneficial Ownership (4)
1/03/202316:32EDGARStatement of Changes in Beneficial Ownership (4)
1/03/202306:30GLOBEBeam Therapeutics to Present at the 41st Annual J.P. Morgan..
12/20/202216:06EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
12/10/202210:00GLOBEBeam Therapeutics Presents First In Vivo Proof of Concept..
12/02/202214:00GLOBEBeam Therapeutics Named to Boston Globe’s Top Places to Work..
12/02/202207:10DJNBeam Therapeutics Says FDA Lifts Clinical Hold on IND..
12/02/202206:30GLOBEBeam Therapeutics Announces FDA Has Lifted the Clinical Hold..
11/30/202206:30GLOBEBeam Therapeutics to Participate in the BofA Securities 2022..
11/14/202206:30GLOBEBeam Therapeutics Enrolls First Patient in BEACON Clinical..
11/09/202206:30GLOBEBeam Therapeutics to Participate in Upcoming Investor..
11/07/202207:36EDGARQuarterly Report (10-q)
11/07/202207:01EDGARCurrent Report Filing (8-k)
11/07/202206:30GLOBEBeam Therapeutics Announces Portfolio Progress and Reports..
11/03/202209:01GLOBEBeam Therapeutics to Present New Preclinical Data..
11/02/202216:31EDGARStatement of Changes in Beneficial Ownership (4)
9/19/202206:30GLOBEBeam Therapeutics Presents First In Vivo Data Demonstrating..
9/07/202206:47EDGARCurrent Report Filing (8-k)
9/02/202216:07EDGARStatement of Changes in Beneficial Ownership (4)
9/02/202216:07EDGARStatement of Changes in Beneficial Ownership (4)
9/02/202216:07EDGARStatement of Changes in Beneficial Ownership (4)
9/01/202206:30GLOBEBeam Therapeutics to Participate at the Wells Fargo 2022..
8/30/202208:17DJNBeam Therapeutics Gets Details of FDA Hold on BEAM-201..
8/30/202207:09EDGARCurrent Report Filing (8-k)
8/11/202210:01GLOBEProKidney Strengthens Board of Directors with Appointments..
8/09/202207:32EDGARQuarterly Report (10-q)
8/09/202207:01EDGARCurrent Report Filing (8-k)
8/09/202206:30GLOBEBeam Therapeutics Announces Pipeline and Business Highlights..
8/08/202216:50EDGARStatement of Changes in Beneficial Ownership (4)
8/02/202208:30GLOBEBeam Therapeutics to Participate in the 2022 Wedbush PacGrow..